Pre-Interview: RA and Nanotechnology with Dr. Massimo Bottini

Pre-Interview: RA and Nanotechnology with Dr. Massimo Bottini

Dr. Massimo Bottini, a bio-engineer using nanotechnology to target and treat rheumatoid arthritis cells, will be the next featured guest on Arthritis Now. Currently with The Sanford Burnham Medical Research Institute in La Jolla, CA, Dr. Bottini’s goal is deliver drug therapies to specific immune cell populations.

Having developed chemically engineered nanoscopic particles which can efficiently and safely bring pharmaceutical and diagnostic agents into selected cells in living animals, his clinical study is targeting drug delivery to Treg (regulatory T cells), which he predicts could offer new approaches using lower doses of drugs, thereby opening new doors for low-risk treatment and/or prevention of rheumatoid arthritis.

Want to find out more about this exciting study? Leave your question in the comment box below for the chance to have it asked directly to Dr. Bottini on our show!

ANRF
Article Author
Arthritis National Research Foundation
arthritisresearch@curearthritis.org

The Arthritis National Research Foundation's mission is to provide initial research funding to brilliant, investigative scientists with new ideas to cure arthritis and related autoimmune diseases. Writing articles about the patients affected and the science being done to find a cure shows why we need to come together to #CureArthritis!

2 Comments
  • Avatar
    Harold Grubs
    Posted at 19:32h, 01 August Reply

    My wife was diagnosed with RA a year ago. Will she ever see a cure and/or get some relief from your research? When will your research be available for the public?

  • Avatar
    Dr Ritu Bajpai
    Posted at 02:00h, 08 June Reply

    Can nanoparticles be used to cover the self proteins (preventing them from binding with immune cells) as in case of ankylosing spondylitis to prevent damage due to cross-reactivity (molecular mimicry)?

Post A Comment